Profiel
Kari Myren is currently Chief Medical Officer at Oncoinvent ASA since 2021.
Former positions include Non-Executive Director at SoftOx Solutions AS, VP-Global Medical Affairs & Clinical Development at Photocure ASA from 2019 to 2021, and Chief Medical Officer at Oncoinvent ASA (Old).
Education includes an undergraduate degree from the University of Oslo.
Actieve functies van Kari Myren
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCOINVENT ASA | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
Eerdere bekende functies van Kari Myren
| Bedrijven | Functie | Einde |
|---|---|---|
| SOFTOX SOLUTIONS | Directeur/Bestuurslid | 24-03-2023 |
| PHOTOCURE ASA | Hoofd Techniek/Wetenschap/O&O | 01-10-2021 |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Kari Myren
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Photocure ASA
Photocure ASA Medical SpecialtiesHealth Technology Develops and sells pharmaceuticals and medical devices | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BerGenBio ASA
BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
SoftOx Solutions AS
SoftOx Solutions AS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures non-toxic & antiseptic medicines | Commercial Services |
















